Elena Aréchaga-Ocampo

Randomized Phase II Trial of All-<i>Trans</i>-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer

Óscar Arrieta, Claudia Haydée González-De la Rosa, Elena Aréchaga-Ocampo et al. · Journal of Clinical Oncology · 2010 · 124 citations · Full text

Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy

José Díaz‐Chávez, Miguel A. Fonseca-Sánchez, Elena Aréchaga-Ocampo et al. · PLoS ONE · 2013 · 71 citations · Full text

New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR

Isidro X. Perez‐Añorve, Claudia Haydée González-De la Rosa, Ernesto Soto‐Reyes et al. · Molecular Oncology · 2019 · 66 citations · Full text

microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration

Miguel A. Fonseca-Sánchez, Carlos Pérez‐Plasencia, Jorge Fernández‐Retana et al. · Oncology Reports · 2013 · 53 citations · Full text

Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells

Alejandro García-Regalado, Miguel Vargas, Alejandro Garcı́a-Carrancá et al. · Molecular Cancer · 2013 · 50 citations · Full text